PubRank

Antoni Noguera-Julian

Author PubWeight™ 22.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet 2011 1.90
2 Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur J Immunol 2012 1.72
3 Fever and skin lesions in a healthy 6-month-old boy. Diagnosis: Ecthyma gangrenosum. Pediatr Infect Dis J 2012 0.99
4 Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens. AIDS 2011 0.95
5 Metabolic and renal adverse effects of antiretroviral therapy in HIV-infected children and adolescents. Pediatr Infect Dis J 2015 0.91
6 Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS 2013 0.90
7 Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: results from a phase 2 open-label trial (DIONE). Pediatr Infect Dis J 2014 0.84
8 Cystatin C: A Marker for Inflammation and Renal Function Among HIV-infected Children and Adolescents. Pediatr Infect Dis J 2016 0.83
9 Metabolic disorders in vertically HIV-infected children: future adults at risk for cardiovascular disease. J Pediatr Endocrinol Metab 2012 0.83
10 Impact of CD4 T cell count on the outcome of planned treatment interruptions in early-treated human immunodeficiency virus-infected children. Pediatr Infect Dis J 2011 0.82
11 Microbial translocation and T cell activation are not associated in chronic HIV-infected children. AIDS 2014 0.82
12 Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues. J Acquir Immune Defic Syndr 2012 0.82
13 Impact of human immunodeficiency virus coinfection on the progression of mother-to-child transmitted hepatitis C virus infection. Pediatr Infect Dis J 2011 0.80
14 No differences of immune activation and microbial translocation among HIV-infected children receiving combined antiretroviral therapy or protease inhibitor monotherapy. Medicine (Baltimore) 2015 0.79
15 Mitochondrial impact of human immunodeficiency virus and antiretrovirals on infected pediatric patients with or without lipodystrophy. Pediatr Infect Dis J 2011 0.79
16 Study of oxidative, enzymatic mitochondrial respiratory chain function and apoptosis in perinatally HIV-infected pediatric patients. Drug Chem Toxicol 2013 0.79
17 Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands. Pediatr Infect Dis J 2014 0.78
18 Premature aging and immune senescence in HIV-infected children. AIDS 2016 0.78
19 Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period. J Clin Virol 2012 0.78
20 The new face of the pediatric HIV epidemic in Western countries: demographic characteristics, morbidity and mortality of the pediatric HIV-infected population. Pediatr Infect Dis J 2015 0.77
21 Impaired cellular immune response to tetanus toxoid but not to cytomegalovirus in effectively HAART-treated HIV-infected children. Vaccine 2013 0.77
22 High-risk alpha-human papillomavirus types: detection in HIV-infected children with acquired epidermodysplasia verruciformis. J Am Acad Dermatol 2013 0.77
23 Mitochondrial assessment in asymptomatic HIV-infected paediatric patients on HAART. Antivir Ther 2011 0.77
24 Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia. Clin Infect Dis 2016 0.77
25 Implementation of occult hepatitis screening in the Spanish cohort of HIV-infected pediatric patients. Pediatr Infect Dis J 2013 0.76
26 Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients: A multicenter study. Medicine (Baltimore) 2016 0.75
27 Normal levels of vitamin D among HIV-infected Catalan pediatric patients. J Acquir Immune Defic Syndr 2012 0.75
28 Impact of the Increased Recommended Dosage of Isoniazid on Pyridoxine Levels in Children and Adolescents. Pediatr Infect Dis J 2016 0.75
29 Metabolic Syndrome in Children and Adolescents Living with HIV. Pediatr Infect Dis J 2016 0.75
30 Adiponectin, Leptin and Inflammatory Markers in HIV-Associated Metabolic Syndrome in Children and Adolescents. Pediatr Infect Dis J 2016 0.75
31 Adherence to Antituberculosis Drugs in Children and Adolescents in a Low-Endemic Setting: A Retrospective Series. Pediatr Infect Dis J 2016 0.75
32 Disseminated Tuberculosis Resulting From Reinfection in a Pediatric Patient Sequentially Treated With Etanercept and Adalimumab. Pediatr Infect Dis J 2017 0.75
33 Strategies for the prevention of mother to child transmission in Western countries: an update. Pediatr Infect Dis J 2015 0.75
34 The role of albuminuria in the follow-up of HIV-infected pediatric patients. Pediatr Nephrol 2014 0.75